Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides and their use

US9051316B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Lars Bärfacker · Oberhausen, DE
• Peter Kolkhof · Wuppertal, DE
• Karl-Heinz Schlemmer · Wuppertal, DE
• Rolf Grosser · Schwandorf, DE
• Adam Nitsche · Pulheim, DE
• Martina Susanne Klein · Mülheim an der Ruhr, DE
• Klaus Münter · Mannheim, DE
• Barbara Albrecht-Küpper · Uerdingen, DE
• Elke Hartmann · Wuppertal, DE

Key dates

• Filing date: Mar 13, 2013
• Grant date: Jun 9, 2015
• Expiry date: Jul 3, 2033

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to novel substituted 4-aryl-1,4-dihydro-1,6-naphthyridine-3-carboxamides, a process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.